Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Is Boston Scientific Stock Outperforming the S&P 500?

With a market cap of $156.3 billion, Boston Scientific Corporation (BSX) is a leading global developer, manufacturer, and marketer of medical devices. The company operates across key segments, including Cardiovascular, Rhythm & Neuro, and MedSurg, offering innovative solutions for heart disease, chronic pain, gastrointestinal, urological, and neurological conditions. 

Companies valued at more than $10 billion are generally considered “large-cap” stocks, and Boston Scientific fits this criterion perfectly. With a diverse portfolio of internally developed and acquired technologies, Boston Scientific leverages both organic innovation and strategic acquisitions to drive growth worldwide.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.